These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3111486)

  • 1. Hepatic cytochrome P-450 system in experimental hepatosplenic schistosomiasis. Presence of an artifact in spectrophotometric analysis.
    el Mouelhi M; Black M; Phillips SM
    Biochem Pharmacol; 1987 Aug; 36(16):2621-6. PubMed ID: 3111486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the oral contraceptive, menstranol, on drug-metabolizing enzymes of female rats in thiamin-supplemented and deficiency states.
    Wade AE; Evans JL; Seitz A
    Pharmacology; 1976; 14(2):104-14. PubMed ID: 822434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the expression of cytochrome P450 isozymes and related carcinogen metabolizing enzyme activities in Schistosoma mansoni-infected mice.
    Sheweita SA; Mubark J; Doenhofe MJ; Mostafa MH; Margison GP; O'Connor PJ; Elder RH
    J Helminthol; 2002 Mar; 76(1):71-8. PubMed ID: 12018200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Schistosoma mansoni infection on the hepatic drug-metabolizing capacity of mice.
    Cha YN; Edwards R
    J Pharmacol Exp Ther; 1976 Nov; 199(2):432-40. PubMed ID: 185361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of hepatic microsomal enzymes in the early phase of murine schistosomiasis.
    Manhães-Rocha DA; Conte FP; Fidalgo-Neto AA; De-Oliveira AC; Ribeiro-Pinto LF; Paumgartten FJ
    Acta Trop; 2005 Jul; 95(1):58-66. PubMed ID: 15862583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH--cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates.
    Yamazaki H; Ueng YF; Shimada T; Guengerich FP
    Biochemistry; 1995 Jul; 34(26):8380-9. PubMed ID: 7599128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of liver microsomal enzymes during the chronic phase of murine schistosomiasis.
    Conte FP; Fidalgo-Neto AA; Manhães-Rocha DA; Paumgartten FJ; De-Oliveira AC
    Braz J Med Biol Res; 2007 May; 40(5):657-62. PubMed ID: 17464427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic cytochrome P450s, phase II enzymes and nuclear receptors are downregulated in a Th2 environment during Schistosoma mansoni infection.
    Mimche SM; Nyagode BA; Merrell MD; Lee CM; Prasanphanich NS; Cummings RD; Morgan ET
    Drug Metab Dispos; 2014 Jan; 42(1):134-40. PubMed ID: 24163175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene B4 omega-hydroxylase in rat liver microsomes: identification as a cytochrome P-450 that catalyzes prostaglandin A1 omega-hydroxylation, and participation of cytochrome b5.
    Sumimoto H; Kusunose E; Gotoh Y; Kusunose M; Minakami S
    J Biochem; 1990 Aug; 108(2):215-21. PubMed ID: 2172223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different levels of Schistosoma mansoni infection induce changes in drug-metabolizing enzymes.
    Sheweita SA; Mangoura SA; el-Shemi AG
    J Helminthol; 1998 Mar; 72(1):71-7. PubMed ID: 9639905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of morphine sulfate on NADPH-cytochrome c reductase and cytochrome P-450 of mouse liver microsomes.
    Datta RK; Johnson EA; Stenger RJ
    Arch Int Pharmacodyn Ther; 1976 Oct; 223(2):180-6. PubMed ID: 826227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of phosphatase on the components of the cytochrome P-450-dependent microsomal monooxygenase.
    Taniguchi H; Pyerin W
    Biochim Biophys Acta; 1987 Apr; 912(3):295-302. PubMed ID: 3105584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hepatic microsomal mixed-function oxidase system in man: cofactor effects and the influence of cholestasis.
    Ahmad N; Black M
    J Pharmacol Exp Ther; 1977 Nov; 203(2):397-408. PubMed ID: 198527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in hepatic xenobiotic-metabolising enzymes in mouse liver following infection with Leishmania donovani.
    Coombs GH; Wolf CR; Morrison VM; Craft JA
    Mol Biochem Parasitol; 1990 Jun; 41(1):17-24. PubMed ID: 2117255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the presence of active cytochrome P450 systems in Schistosoma mansoni and Schistosoma haematobium adult worms.
    Saeed HM; Mostafa MH; O'Connor PJ; Rafferty JA; Doenhoff MJ
    FEBS Lett; 2002 May; 519(1-3):205-9. PubMed ID: 12023046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE; Evans JS; Holmes D; Baker MT
    Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Schistosoma mansoni infection and treatment on drug metabolizing enzymes.
    Ebeid FA; Seif el-Din SH; Ezzat AR
    Arzneimittelforschung; 2000 Sep; 50(9):867-74. PubMed ID: 11050708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat oesophageal cytochrome P450 (CYP) monooxygenase system: comparison to the liver and relevance in N-nitrosodiethylamine carcinogenesis.
    Pinto LF; Moraes E; Albano RM; Silva MC; Godoy W; Glisovic T; Lang MA
    Carcinogenesis; 2001 Nov; 22(11):1877-83. PubMed ID: 11698352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation and detoxification metabolism of urban air pollutants 2-nitrobenzanthrone and carcinogenic 3-nitrobenzanthrone by rat and mouse hepatic microsomes.
    Stiborova M; Cechova T; Borek-Dohalska L; Moserova M; Frei E; Schmeiser HH; Paca J; Arlt VM
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():8-15. PubMed ID: 23353838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.